Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−9.70 TWD
−2.31 B TWD
62.68 M TWD
225.02 M
About OBI Pharma, Inc.
Sector
Industry
CEO
Heidi Wang
Website
Headquarters
Taipei
Founded
2002
ISIN
TW0004174008
FIGI
BBG003PBPW85
OBI Pharma, Inc. engages in the development and licensing of novel therapeutic agents for unmet medical needs against cancer. Its products include Adagloxad Simolenin, which is a late-stage novel active immune-oncology Globo Series-based therapeutic vaccine for the treatment of epithelial cancers, such as breast, ovarian, lung, prostate, colon, gastric, and pancreatic cancer. The company was founded by Michael N. Chang on April 29, 2002 and is headquartered in Taipei, Taiwan.
Related stocks
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 4174 is 26.45 TWD — it has decreased by −0.75% in the past 24 hours. Watch OBI Pharma, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TPEX exchange OBI Pharma, Inc. stocks are traded under the ticker 4174.
4174 stock has fallen by −2.04% compared to the previous week, the month change is a 2.12% rise, over the last year OBI Pharma, Inc. has showed a −60.99% decrease.
We've gathered analysts' opinions on OBI Pharma, Inc. future price: according to them, 4174 price has a max estimate of 29.00 TWD and a min estimate of 29.00 TWD. Watch 4174 chart and read a more detailed OBI Pharma, Inc. stock forecast: see what analysts think of OBI Pharma, Inc. and suggest that you do with its stocks.
4174 reached its all-time high on Dec 18, 2015 with the price of 736.40 TWD, and its all-time low was 25.05 TWD and was reached on Sep 15, 2025. View more price dynamics on 4174 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
4174 stock is 2.29% volatile and has beta coefficient of 0.70. Track OBI Pharma, Inc. stock price on the chart and check out the list of the most volatile stocks — is OBI Pharma, Inc. there?
Today OBI Pharma, Inc. has the market capitalization of 6.96 B, it has decreased by −4.07% over the last week.
Yes, you can track OBI Pharma, Inc. financials in yearly and quarterly reports right on TradingView.
OBI Pharma, Inc. is going to release the next earnings report on Oct 31, 2025. Keep track of upcoming events with our Earnings Calendar.
4174 net income for the last quarter is −653.50 M TWD, while the quarter before that showed −511.55 M TWD of net income which accounts for −27.75% change. Track more OBI Pharma, Inc. financial stats to get the full picture.
No, 4174 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. OBI Pharma, Inc. EBITDA is −2.22 B TWD, and current EBITDA margin is −3.43 K%. See more stats in OBI Pharma, Inc. financial statements.
Like other stocks, 4174 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade OBI Pharma, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So OBI Pharma, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating OBI Pharma, Inc. stock shows the sell signal. See more of OBI Pharma, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.